Massive Bio, the biotech startup focused on precision medicine and AI-enabled patient-centric clinical trial enrollments, has raised $2.6M in additional funding from investors that include Revo Capital and Cavendish Impact Foundation via ImpactAssets. Founded by Arturo Loaiza-Bonilla, Cagatay Culcuoglu, and Selin Kurnaz in 2015, Massive Bio has now raised a total of $6.6M in reported equity funding.

The AlleyWatch audience is driving progress and innovation on a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the New York business community and beyond. Find out more here.